Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$13.47M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
178.81%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$6.672M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$6.659M

Stock Price

Loading...
Market Cap: $5.054 Million

About Artelo Biosciences Inc

Artelo Biosciences Inc (ARTL) is a biosciences company listed on The Nasdaq Stock Market LLC. The filing excerpts provided from the 10-K filed 2026-02-24 (accession 000164033426000368) do not contain sufficient detail to characterize the company's core business activity, revenue model, competitive position, products, customers, or financial results. The excerpts consist primarily of boilerplate SEC cover page text, table of contents entries, and forward-looking statement disclaimers, with no substantive business description, segment data, or operational disclosures included. A complete business summary cannot be prepared without material content from the Business, MD&A, or Financial Statements sections of the filing.

Source: SEC 10-K, filed 2026-02-24

Industry: Pharmaceutical Preparations Peers: CLS Holdings USA, Inc. Adial Pharmaceuticals Inc Emmaus Life Sciences Inc GB SCIENCES INC Johnson & Johnson Range Impact Inc Palisade Bio Inc Petros Pharmaceuticals Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support